Indivior to appeal court verdict over Suboxone Film patents


Indivior, which specialises in addiction treatment drugs, intends to launch an appeal against a US District Court for the District of Delaware verdict that could lead to rival companies selling a generic version of its Suboxone Film, a drug to treat opioid addiction. 

Indivior, US District Court for the District of Delaware, US Food and Drug Administration, Abbreviated New Drug Applications, Shaun Thaxter, patent

More on this story

Indivior settles generic dispute with Mylan